GlassScriptPhysician profile
Jonna G Webb
NPI 1881888980
$2,727.49
in general payments reported to CMS, 2019-2025
13 companies · $697 in 2025
The $697 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $721 · 2024: $1,156 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,313.81 |
| Education | $260.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $404.03 | 2022-2025 | |
| Janssen Biotech, INC. | $327.66 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $288.39 | 2023-2025 | |
| Galderma Laboratories, L.P. | $288.32 | 2024 | |
| Leo Pharma INC. | $268.71 | 2023-2025 | Adbry, Anzupgo |
| Incyte Corporation | $210.01 | 2023-2025 | Opzelura, Opzelura |
| E.R. Squibb & Sons, L.L.C. | $209.11 | 2023-2025 | Sotyktu |
| Abbvie INC. | $182.12 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $173.31 | 2022-2024 | Ilumya |
| Lilly USA, LLC | $167.67 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $141.05 | 2024 | Bimzelx |
| Amgen INC. | $53.36 | 2023-2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.75 | 2023 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonna Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.